CLINICAL_TRIALS
trial_result
· 2022-11-14
Clinical Trial Update: Extension Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis [Phase 3]
Summary
Phase 3 extension study evaluating etanercept in three subtypes of juvenile arthritis has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Juvenile Idiopahtic Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2022-11-14